Q2 Quick Note #07: Carbamazepine Improves Memory in Kcnq2 Mouse Model
Published on January 7, 2026
Researchers treated mice carrying a Kcnq2 gene variant with a sodium channel-blocking drug called carbamazepine. Mice that received the drug had fewer seizures and performed better on memory-related tests compared to mice given a placebo.
What It’s About
Scientists studied mice that were genetically modified to carry the same KCNQ2 gene variant found in a person with KCNQ2-DEE. From a young age, the mice were given food containing the drug carbamazepine. The treatment not only reduced seizures, but also improved performance in tests measuring how well the mice could learn and remember important locations (like remembering where you parked your car). Animals that were given carbamazepine made fewer errors and found the correct spot more quickly than those that were given a placebo. Future studies will need to investigate whether these cognitive benefits came directly from the drug itself or simply from stopping the seizures.
Why It Matters
Mouse models help us figure out whether a drug might be worth trying out in people. These studies provide encouraging evidence that carbamazepine could do more than just reduce seizures in DEEs.
The Quick Term
Cognitive: Related to processes involved in learning, memory, attention, and problem-solving.
Link